Director Alan L. Felder awarded 12,401 DHC (NASDAQ: DHC) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Felder Alan L. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Alan L. Felder received an award of 12,401 Common Shares of Beneficial Interest on 2026-06-10. The shares were granted at no cash cost to him pursuant to the company’s equity compensation plan.
Following this grant, Felder directly holds 75,124 common shares, as reported in the filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Felder Alan L.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares of Beneficial Interest | 12,401 | $0.00 | -- |
Holdings After Transaction:
Common Shares of Beneficial Interest — 75,124 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 12,401 shares
Grant price per share: $0.0000 per share
Shares held after grant: 75,124 shares
3 metrics
Shares granted
12,401 shares
Award under equity compensation plan on 2026-06-10
Grant price per share
<money>$0.0000</money> per share
Reported transaction price for share award
Shares held after grant
75,124 shares
Total direct holdings following transaction
Key Terms
Common Shares of Beneficial Interest, equity compensation plan, Grant, award, or other acquisition, Form 4
4 terms
equity compensation plan financial
"Shares were awarded pursuant to the issuer's equity compensation plan"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
Grant, award, or other acquisition financial
"Transaction code A is described as Grant, award, or other acquisition"
Form 4 regulatory
"The insider transaction is disclosed in a Form 4 filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did DHC director Alan L. Felder report on this Form 4?
Alan L. Felder reported receiving an award of 12,401 Common Shares of Beneficial Interest in Diversified Healthcare Trust. The filing shows this was a share grant, not an open-market trade, made under the company’s equity compensation plan.
What are Alan L. Felder’s DHC holdings after the reported transaction?
After the share award, Alan L. Felder directly holds 75,124 Common Shares of Beneficial Interest in Diversified Healthcare Trust. This total reflects his position immediately following the 12,401-share grant disclosed in the Form 4 filing for the June 10, 2026 transaction date.
Was Alan L. Felder’s DHC transaction a purchase or a grant?
The transaction was a grant, not a purchase. The Form 4 lists transaction code “A” with a description of “Grant, award, or other acquisition,” and the footnote states the shares were awarded under Diversified Healthcare Trust’s equity compensation plan at a price of $0.0000 per share.